Microglial Activation Modulates Neuroendocrine Secretion During Experimental Sepsis

Area of Science:

• Neuroscience
• Immunology
• Endocrinology

Background:

• Sepsis induces central nervous system (CNS) inflammation, impacting autonomic, cognitive, and endocrine functions.
• Microglial activation in the CNS during sepsis suggests their role in observed central alterations.
• Understanding microglial involvement in neuroendocrine regulation during systemic inflammation is crucial.

Purpose of the Study:

• To investigate the role of microglial activation in neuroendocrine system function during sepsis-induced systemic inflammation.
• To determine the effects of microglial inhibition on hormonal parameters and inflammatory mediators in a rat sepsis model.

Main Methods:

• Wistar rats underwent cecal ligation and puncture to induce sepsis.
• Minocycline, a microglial activation inhibitor, was administered intracerebroventricularly before sepsis induction.
• Hormonal levels, central/peripheral inflammation markers, apoptosis, and synaptic function in the hypothalamus were analyzed at 6 and 24 hours post-surgery.

Main Results:

• Minocycline administration reduced inflammatory mediators and apoptosis markers, particularly at 24 hours post-sepsis.
• Microglial inhibition altered plasma hormone levels: decreased oxytocin and increased corticosterone/vasopressin at 6 hours; decreased oxytocin and increased ACTH/corticosterone at 24 hours.
• Prolactin levels remained unaffected by minocycline treatment.

Conclusions:

• Microglial activation plays a differential role in modulating hormone secretion during sepsis.
• This modulation is closely linked to the production of central and peripheral inflammatory mediators.
• Targeting microglial activation may offer therapeutic strategies for sepsis-associated neuroendocrine dysfunction.